Deutsche Bank Ag\ Precision Biosciences Inc Transaction History

Deutsche Bank Ag\

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.22 - $40.8 $646 - $21,624	530 Added 0.45%	118,462 $154,000
Q2 2022 Aug 11, 2022	SELL	$1.15 - $3.34 $81,042 - $235,376	-70,472 Reduced 37.4%	117,932 $189,000
Q1 2022 May 13, 2022	SELL	$2.96 - $7.76 $13,968 - $36,619	-4,719 Reduced 2.44%	188,404 $580,000
Q4 2021 Feb 11, 2022	BUY	$7.4 - $11.66 $897,353 - $1.41 Million	121,264 Added 168.75%	193,123 $1.43 Million
Q3 2021 Nov 04, 2021	SELL	$9.18 - $14.15 $135,726 - $209,207	-14,785 Reduced 17.06%	71,859 $829,000
Q2 2021 Aug 11, 2021	BUY	$8.07 - $12.52 $212,838 - $330,202	26,374 Added 43.76%	86,644 $1.08 Million
Q1 2021 May 13, 2021	BUY	$8.57 - $15.79 $76,324 - $140,625	8,906 Added 17.34%	60,270 $623,000
Q4 2020 Feb 16, 2021	BUY	$5.98 - $12.47 $151,365 - $315,640	25,312 Added 97.16%	51,364 $429,000
Q3 2020 Nov 12, 2020	BUY	$4.65 - $8.73 $10,271 - $19,284	2,209 Added 9.26%	26,052 $160,000
Q2 2020 Aug 13, 2020	BUY	$4.66 - $8.7 $52,583 - $98,170	11,284 Added 89.85%	23,843 $199,000
Q1 2020 May 14, 2020	SELL	$5.05 - $15.01 $3,666 - $10,897	-726 Reduced 5.46%	12,559 $76,000
Q4 2019 Feb 14, 2020	BUY	$6.32 - $19.66 $67,706 - $210,617	10,713 Added 416.52%	13,285 $184,000
Q3 2019 Nov 14, 2019	SELL	$8.03 - $14.82 $74,140 - $136,833	-9,233 Reduced 78.21%	2,572 $20,000
Q2 2019 Aug 14, 2019	BUY	$11.88 - $16.94 $140,243 - $199,976	11,805 New	11,805 $156,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $554M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.